China's financial regulators had two meetings on the calendar for November 2, 2026. Caijing magazine reported that the People's Bank of China (PBOC) and the China Securities Regulatory Commission (CSRC) would meet with some securities firms and fund companies to study how to promote the use of capital-market support tools, and that the PBOC, the National Financial Regulatory Administration (NFRA) and the CSRC would gather major banks to study optimizing the share buyback and increase re-lending policy[1][3]. Shanghai Securities News had filed its account at 16:20 Beijing time the previous day on the China Securities Network platform[2], adding that some securities firms and fund companies had already received notices to attend[3]. Caijing's version followed at 07:49 on November 2[1].
The meetings put a two-year-old toolkit back at the center of policy communication, and what the public record supports saying about that today concerns agenda and attention. Neither meeting had concluded when the reports surfaced, and no official readout existed at that point. The item climbed to eighth place on Baidu's hot list by 08:00 Beijing time on expectation rather than on any meeting outcome. Xiaoxiang Morning Herald's headline reads "A-shares get good news" and adds that "the industry expects stabilization measures to repair sentiment"[4].
The agenda points at two specific tools
The first tool named in the reporting is the Securities, Funds and Insurance companies Swap Facility (SFISF). PBOC governor Pan Gongsheng unveiled it at a September 24, 2024 press conference as one of two measures to support the stock market, and the central bank's open market desk set it up by announcement on October 10, 2024[1][5]. Eligible securities firms, fund managers and insurers pledge bonds, stock ETFs or CSI 300 constituent stocks, among other assets, and swap them for high-grade liquid assets such as Treasury bonds and central bank bills. The first operation scale was set at 500 billion yuan with room to expand[5]. The design lets these institutions obtain central-bank liquidity against holdings they already own, a purpose the creation notice ties to building a long-term mechanism that strengthens the capital market's own stability[1][5].
The second is the share buyback and increase re-lending, established by a notice the three agencies signed on October 17, 2024[6]. Twenty-one national financial institutions lend to listed companies and major shareholders for buybacks and share increases, the PBOC refinances 100 percent of loan principal at 1.75 percent a year on one-year terms that can be extended, and client loan rates are in principle capped at 2.25 percent[6]. Loan funds stay in dedicated accounts on a closed loop, companies under delisting risk warnings are excluded, and the notice defines the policy as a temporary arrangement[6].
Both meetings on November 2 therefore have concrete subjects. On May 7, 2025, the two quotas were merged into a combined 800 billion yuan, and structural policy tool rates were cut 0.25 percentage points, taking special structural tool rates to 1.5 percent[7]. That combined figure is a ceiling. How much has actually been drawn is a separate question, and the record answers it with dated numbers.
Used, but far from the 800 billion yuan ceiling
As of the PBOC's January 23, 2025 disclosure, the swap facility had been drawn twice, for a cumulative 105 billion yuan[1]. The first operation, announced October 21, 2024, amounted to 50 billion yuan, with 20 institutions bidding and a winning fee rate of 0.20 percent[8]. The second, tendered January 2, 2025, brought in 55 billion yuan at a winning rate of 0.10 percent[9]. By that same January date, more than 300 listed companies had disclosed plans to apply for buyback loans with amount caps above 60 billion yuan[1].
The usage record grew through the spring. Financial News reported in May 2025 that since April 2025 more than 300 listed companies had disclosed buyback or increase plans with caps above 100 billion yuan, that China Chengtong Holdings and China Reform Holdings had announced plans to use a combined 180 billion yuan of such loans, and that by the end of April 2025 disclosed loan applications exceeded 110 billion yuan while signed contracts stood around 200 billion yuan[7]. The same report put actual lending rates at about 2 percent, citing industry insiders[7]. Set against the combined 800 billion yuan quota, swap draws of 105 billion yuan as of January 2025 and signed re-lending contracts of about 200 billion yuan as of April 2025 remain well inside the ceiling[1][7].
April 8, 2025 shows how the wider state response looked on a stress day. Central Huijin, the state investment company, said it had again increased its holdings of exchange-traded funds, the PBOC pledged to provide ample re-lending support for such purchases when necessary, and the Shanghai Composite Index closed 1.58 percent higher that day[10]. The same-day gains do not by themselves show how much of the rebound the package caused.
The CSRC's October moves came first
The meetings follow an October 2026 in which the CSRC was already sequencing public moves. Caijing's market data put the ChiNext Index down 23.02 percent and the STAR 50 down 24.13 percent for the month, both more than 40 percent below their July levels[1]. On October 10, CSRC chairman Wu Qing held an expert symposium whose readout listed stronger stabilization mechanisms, broader medium- and long-term funding channels, larger dividends and buybacks, and more policy tools in reserve among experts' suggestions[11]. On October 19, Wu Qing told the Financial Street Forum annual conference that policy would put stability first and warned specifically about offshore leveraged products linked to individual A-share stocks. The CSRC registered the first batch of 18 active ETFs that day, an approval announced in the speech[12]. Caijing's follow-up reporting said 15 of those funds had completed fundraising by October 30, collecting 18 billion yuan from more than 160,000 investors, with institutions accounting for over 25 percent of subscriptions[1].
The October 30 CSRC party committee (expanded) meeting belongs in this sequence with a caveat. Its readout is primarily a party-discipline document, and the market-stabilization language appears once, in the closing requirements, as a call to stabilize the market and expectations[13].
Analysts frame the same evidence with different weight. Li Qiusuo, chief domestic strategy analyst at CICC Research, wrote that the recent valuation reset was driven mostly by external shocks and sentiment rather than deteriorating fundamentals, and put the CSI 300 forward price-to-earnings ratio at 11.8 times at its low, below its ten-year average, with the ChiNext forward multiple at the 2.8th percentile of the past decade[1]. Zhou Junzhi, chief macro analyst at CSC Financial, wrote that the sell-off reflected overseas volatility and shifting external risk appetite, and that a short-term price correction does not amount to a reversal of the long-term trend[1].
What would change the reading
Three developments would move the story from agenda to action. An official readout of either meeting would be the first, and the October 10 symposium shows the format, with the CSRC posting its readout the same evening[11]. New operations would be the second. The swap facility's usage has been published through numbered PBOC operation announcements, the format of the October 2024 and January 2025 operations[8][9]. Allocation news would be the third. The PBOC said in January 2025 that it would keep optimizing the tools and widen their use over time[1], and one report credited to People's Finance on the Shanghai Securities News page said a state-owned megabank plans new buyback-loan quotas of up to 100 billion yuan for each of China Chengtong and China Reform, a single-outlet figure no official release has confirmed[3].
As reported, the November 2 meetings mean the policy environment keeps prioritizing market stabilization through the same named, funded instruments, a playbook assembled in 2024, merged into one quota in May 2025 and used at dated volumes through spring 2025. What they do not yet supply is an outcome, a new operation, or any official text. Those arrive, if they do, in releases that can be checked by name and date. Until then the reading the evidence supports stays at attention and agenda, and the sentiment story circulating under the "good news" headline remains expectation attributed to media reports and analyst comments[4][1].